Robinhood’s Revealing Ad Pitch: We’re All Investors, Alone
The latest Robinhood campaign is more raspberry than rah rah.
Read more...The latest Robinhood campaign is more raspberry than rah rah.
Read more...How Bitcoin hard-core loyalists see the future of their project.
Read more...And you believed Biden on climate change?
Read more...Michael Hudson gives another wide-ranging, tour de force interview. Enjoy!
Read more...Last week, President Joe Biden and Apple co-founder Steve Wozniak endorsed the right to repair.
Read more...The opioid crisis provides a deadly example of why innovation often is simply a new-fangled form of predation.
Read more...The more you look at aducanumab, both the dubious FDA approval and the thin odds that it will perform medically, the less there is to like.
Read more...Whistleblowers charge that Trump-style doctoring of scientific reports is continuing under Biden.
Read more...Intel is the poster child of how stock buybacks come at the cost of technological innovation.
Read more...Another big and costly dustup over Chinese listings in the US. But now Chinese officials signal they want broad-scale change.
Read more...Yves here. We’re doing a bit of catchup by featuring some significant stories that were still crowded out a bit due to the competing news plus the Fourth of July tuneout. One is on the super dodgy approval of the big ticket, very dubious effectiveness Alzheimer’s drug Aducanumab. And “big ticket” is no understatement; the […]
Read more...The Democrat plan to privatize Medicare by expanding the private, for-profit Medicare Advantage program
Read more...The health care grift knows as surprise billing is about to be largely stamped out.
Read more...Amazon looks to be having a meltdown over new FTC chief Lina Khan. Good.
Read more...Why colonoscopy testing looks an awful lot like neoliberal rent extraction, as least as practiced in the US.
Read more...